Variable | Number of patients | Data presentation |
---|---|---|
Age (years + SD) d (years, IQR) | 179 | 47.5 ± 14.83 a 49 (36–57) b |
Sex c | ||
Female | 110 | 61.4% |
BMI e | 179 | 26.5 ± 3.79 a 26 (IQR 24–29) b |
ASA class c | ||
I | 72 | 40.78% |
II | 101 | 56.42% |
III | 5 | 2.79% |
IV y V | 0 | 0% |
Comorbidities | ||
Arterial hypertension c | 35 | 19.55% |
Coronary disease c | 3 | 1.68% |
Diabetes c | 11 | 6.15% |
Hypothyroidism c | 16 | 8.94% |
Cancer c | 2 | 1.12% |
Pulmonary disease c | 5 | 2.80% |
CKDc | 0 | 0% |
Rheumatoid arthritis c | 3 | 1.69% |
Others c | 2 | 1.12% |
HIV c | 0 | 0.% |
Smoking c | 29 | 16.20% |
Surgery location c | ||
Puente Aranda | 142 | 79.33% |
Clínica Colombia | 37 | 20.67% |
Operation duration (min)f | 179 | 69.4 ± 39.2 a 60 (IQR 50-80) b |
Postoperative hospitalization c | ||
No | 175 | 97.77% |
Yes | 4 | 2.23% |
Anesthesia type c | ||
General | 71 | 39.66% |
Spinal | 72 | 40.22% |
Blockade | 5 | 2.79% |
Local | 4 | 2.23% |
Combined | 27 | 15.08% |
Contact with individuals with COVID-19 c | 5 | 2.79% |
Presence of symptoms c | 4 | 2.23% |
Medical attention c | 2 | 1.12% |
Developed COVID-19c | 0 | 0% |
Tests for COVID-19 c | 2 | 1.12% |